Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 789 full-time employees The company went IPO on 2013-05-07. The firm operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Beijing Tong Ren Tang Chinese Medicine Company Limited의 CEO는 누구입니까?
Mr. Chi Wang은 2024부터 회사에 합류한 Beijing Tong Ren Tang Chinese Medicine Company Limited의 Chief Executive Officer입니다.
BEIJING TONG REN TANG CHINESE M 주식의 가격 성능은 어떻습니까?
BEIJING TONG REN TANG CHINESE M의 현재 가격은 $0.6484이며, 전 거래일에 감소된 0% 하였습니다.
Beijing Tong Ren Tang Chinese Medicine Company Limited의 주요 사업 주제나 업종은 무엇입니까?
Beijing Tong Ren Tang Chinese Medicine Company Limited은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Beijing Tong Ren Tang Chinese Medicine Company Limited의 시가총액은 얼마입니까?
Beijing Tong Ren Tang Chinese Medicine Company Limited의 현재 시가총액은 $542.7M입니다
Beijing Tong Ren Tang Chinese Medicine Company Limited는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 4명의 분석가가 Beijing Tong Ren Tang Chinese Medicine Company Limited에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 5명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다